2014
DOI: 10.1016/j.fct.2013.12.030
|View full text |Cite
|
Sign up to set email alerts
|

Licochalcone B inhibits growth of bladder cancer cells by arresting cell cycle progression and inducing apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
46
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 48 publications
(46 citation statements)
references
References 34 publications
0
46
0
Order By: Relevance
“…Licochalcone-A, a chalconoid and a type of natural phenol, has been isolated from the root of the licorice plant and has exhibited various pharmacological effects, including antimalarial, anticancer, antibacterial and antiviral properties (7). Furthermore, treatment with licochalcone-A induced apoptosis in various cancer cell types, including oral (36), bladder (37,38), lung (39), gastric (40) and prostate cancer cells (41). In addition, Lico-E, a retrochalone, with various pharmacological effects, including antiparasitic, antibacterial, antioxidative and superoxide-scavenging properties, has been isolated from the root of licorice (24).…”
Section: Discussionmentioning
confidence: 99%
“…Licochalcone-A, a chalconoid and a type of natural phenol, has been isolated from the root of the licorice plant and has exhibited various pharmacological effects, including antimalarial, anticancer, antibacterial and antiviral properties (7). Furthermore, treatment with licochalcone-A induced apoptosis in various cancer cell types, including oral (36), bladder (37,38), lung (39), gastric (40) and prostate cancer cells (41). In addition, Lico-E, a retrochalone, with various pharmacological effects, including antiparasitic, antibacterial, antioxidative and superoxide-scavenging properties, has been isolated from the root of licorice (24).…”
Section: Discussionmentioning
confidence: 99%
“…Licochalcone B led to S-phase arrest, decreased the expression of cyclin A, CDK1, CDK2 mRNA, Bcl-2, survivin, and cell division cycle 25 (Cdc25A and Cdc25B) proteins, induced downregulation of antiapoptotic proteins (Bid, Bcl-xl, and Mcl-1), and also caused the loss of [43,44]. However, it enhanced Bax expression, activated caspase-3, and cleaved poly ADP-ribose polymerase (PARP) protein [44]. In addition, it attenuated migration, adhesion, and invasion of cancer cells accompanied with the downregulated protein expression of MMP-9 and nuclear translocation of nuclear factor-κB (NF-κB) [115].…”
Section: Anticancer Activitymentioning
confidence: 99%
“…DDP is a novel licochalcone B derivative which has 3,4-dihydroxy-2-methoxy substituent and a resorcinol type ring A. Although licochalcone B has several pharmacological attributes including anti-cancer [15], anti-oxidant, and anti-inflammatory [16,17] activity, no report on DPP's anti-inflammatory activities or the molecular mechanisms involved has been published.…”
Section: Introductionmentioning
confidence: 98%